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Objective: To prospectively compare chemical-exchange saturation-transfer (CEST) with delayed
gadolinium-enhanced MRI of cartilage (dGEMRIC) and T2 mapping to assess the biochemical cartilage
properties of the knee.
Method: Sixty-nine subjects were prospectively included (median age, 42 years; male/female ¼ 32/37) in
three cohorts: 10 healthy volunteers, 40 patients with clinically suspected cartilage lesions, and 19 pa-
tients about 1 year after microfracture therapy.
T2 mapping, dGEMRIC, and CEST were performed at a 3 T MRI unit using a 15-channel knee coil.
Parameter maps were evaluated using region-of-interest analysis of healthy cartilage, areas of chon-
dromalacia and repair tissue. Differentiation of damaged from healthy cartilage was assessed using
receiver-operating characteristic (ROC) analysis.
Results: Chondromalacia grade 2e3 had signiﬁcantly higher CEST values (P ¼ 0.001), lower dGEMRIC
(T1-) values (P < 0.001) and higher T2 values (P < 0.001) when compared to the normal appearing
cartilage. dGEMRIC and T2 mapping correlated moderately negative (Spearman coefﬁcient r ¼ 0.56,
P ¼ 0.0018) and T2 mapping and CEST moderately positive (r ¼ 0.5, P ¼ 0.007), while dGEMRIC and CEST
did not signiﬁcantly correlate (r ¼ 0.311, P ¼ 0.07). The repair tissue revealed lower dGEMRIC values
(P < 0.001) and higher CEST values (P < 0.001) with a signiﬁcant negative correlation (r ¼ 0.589,
P ¼ 0.01), whereas T2 values were not different (P ¼ 0.54). In healthy volunteers’ cartilage, CEST and
dGEMRIC showed moderate positive correlation (r ¼ 0.56), however not reaching signiﬁcance (P ¼ 0.09).
ROC-analysis demonstrated non-signiﬁcant differences of T2 mapping vs CEST (P ¼ 0.14), CEST vs
dGEMRIC (P ¼ 0.89), and T2 mapping vs dGEMRIC (P ¼ 0.12).
Conclusion: CEST is able to detect normal and damaged cartilage and is non-inferior in distinguishing
both when compared to dGEMRIC and T2 mapping.
 2014 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Osteoarthritis (OA) of the knee has high socioeconomic
impact1,2, is a main source of pain and might eventually end innd Interventional Radiology,
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ternational. Published by Elsevier Lendoprosthesis3e5. Since untreated injuries of the articular carti-
lage in young patients may result in premature OA6, early detection
of cartilage damage is paramount to prevent further progression.
Two main processes within the hyaline cartilage are considered an
early event in degeneration leading to OA: the loss of glycosami-
noglycans (GAG) and the disturbance of the 3D collagen network7.
Several biochemical or “compositional”8,9 magnetic resonance
imaging (MRI) techniques have been proposed to assess these
processes, such as delayed gadolinium-enhanced MRI of cartilage
(dGEMRIC), 23Na MRI, and T1 rho mapping to assess the GAG
content, and T2 mapping to evaluate the water content and dam-
ages to the collagen network. A new promising technique is CEST
(chemical exchange saturation transfer) without the need oftd. All rights reserved.
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GAG (thus also named gagCEST)10 and to correlate with 23Na MRI,
which is thought to directly measure GAG at 7 T11. CEST has shown
the potential to measure GAG also at 3 T12,13. Drawbacks of these
methods are: not GAG-speciﬁc (T1rho14) or non-feasible at clinical
MRI systems (23Na needs ultra-highﬁeld MRI and dedicated hard-
ware9). In areas of GAG loss, CEST and dGEMRIC are reported to
produce reduced values15,16, while T2 values are expected to in-
crease in damaged cartilage17e21. Hypothetically, CEST and dGEM-
RIC should be positively correlated while both should be negatively
correlated with T2 mapping in damaged cartilage.
Until now, CEST has not been used in a clinical setting at 3 T to
investigate the knee’s cartilage properties and a systematic pro-
spective comparison with the more established techniques
dGEMRIC and T2 mapping is lacking. Thus, we compared CEST with
dGEMRIC and T2 mapping regarding the ability to detect normal
and damaged cartilage both in young healthy volunteers and in
patients with chondromalacia or repair cartilage after micro-
fracture therapy (MFX).
Method
Patient enrollment
The study was approved by the institutional review board and
conducted according to the declaration of Helsinki. Informed con-
sent was obtained from all patients after the nature of the exami-
nation had been fully explained. Sixty-nine patients were
prospectively included (median age, 42 years; range, 12e76 years,
37 females and 32 males). All patients underwent a standardized
clinical examination by an orthopedic surgeon according to the
ICRS recommendations22. Three subcohorts were included to allow
for the evaluation of normal cartilage, areas of chondromalacia and
damaged repair cartilage after cartilage therapy.
First cohort: healthy volunteers
10 young healthy volunteers (median age 24.5 years, range 20e
50 years) without any prior surgery on their lower extremities or
any clinical complaints regarding their locomotors system were
included. Physical examination was normal. Healthy cartilage was
further conﬁrmed using morphological MRI which showed entirely
normal cartilage in all sequences including proton density
weighted fat-saturated sequences23.
Second cohort: chondromalacia group
40 consecutive patients (median age, 47 years; range 12e76
years) that presented with knee pain and clinically suspected
cartilage lesions were included to allow analyzing areas of chon-
dromalacia in comparison to adjacent morphologically normal-
appearing cartilage. We excluded patients with lack of normal
cartilage (no intraindividual comparison), grade 4 (no measurable
cartilage layer) and grade 1 lesions (great variety of internal signal
changes, underlying pathology not clearly deﬁned). Thus, the in-
clusion criteriawere grade 2 and 3 cartilage lesions according to the
modiﬁed Noyes score24,25. From 41 patients in this group, one had
to be excluded who underwent the full MRI study protocol but did
not show any normal-appearing cartilage.
Third cohort: repair cartilage group
19 consecutive patients (median age, 43 years; range, 15e62)
who underwent MRI about 1 year (mean, 12.8 months; range, 8e26
months) after surgical cartilage repair. The time-interval was chosenbecause in the ﬁrst months after therapy, there are ongoing repair
processes that would limit the interindividual comparability26. The
treatment consisted of marrow stimulation by arthroscopical
microfracturing. Microfractures were generated with specially bent
awls (ChondroPick, Arthrex, Naples, Fl, USA) by creating V-shaped
perforation holes (3-4 holes/cm2). Bone marrow bleeding from the
perforation holes was checked after shutting off the water inﬂux.
Demographic data and distribution of age
The median age of the 69 included individuals was 42 years
(range, 12e76 years). The distribution of age in the three groups
was comparable between group 2 and group 3 (median age 47 vs 43
years), i.e., not statistically signiﬁcant different. However, group 1
with amedian age of 24.5 years was statistically signiﬁcant younger
when compared to group 2 (P¼ 0.003) and group 3 (P¼ 0.013). As a
consequence, the inﬂuence of age regarding the evaluation of the
cartilage is minimized when comparing the similar-aged groups 2
and 3, while an additional effect of age may potentially be present
when comparing group 1 with the other two groups. However, the
younger age is attributed to the study design, as wewanted to have
a group with entirely normal cartilage. The highest likelihood of
normal cartilage has a young-aged group, when conﬁrmation by
arthroscopy and biopsy is not available.
MRI protocol and data post-processing
MRI was performed on a 70 cm open-bore 3-T whole-body
scanner (MAGNETOM Verio, Siemens Healthcare, Erlangen, Ger-
many), equipped with an 18-channel total-imaging matrix (Tim
[102  18] conﬁguration) in combination with a dedicated 15-
channel knee coil. Standard and functional MRI was performed
during the same session. The MRI protocol consisted of the
following sequences: Morphological sequences: Localizer, proton-
density (PD)-weighted turbo spin-echo (TSE) with and without
fat saturation and T1-weighted spin-echo sequences. Functional
sequences: (detailed description below), prescan MAPit T1 volu-
metric interpolated breath hold examination (VIBE), gagCEST, T2
map, contrast agent administration, 90 min delay, post-contrast
MAPit T1-VIBE (dGEMRIC).
For gagCEST, a modiﬁed and segmented three-dimensional (3D)
radiofrequency (RF)-spoiled sagittal gradient-echo sequence (TR/TE,
778/3.59 ms, voxel size 0.625  0.625  3.3 mm3, acquisition time
11:12 min, generalized autocalibrating partially parallel acquisitions
(GRAPPA) acceleration by a factor of 2) was used. Prior to image
acquisition, a series of three Gaussian-shaped RF pulses followed by
gradients in x, y, and z directions to spoil residualmagnetizationwere
applied for pre-saturation of proton resonances at different offset
frequencies on each spectral side of the bulk water resonance. The
pulse train was repeated every 90 lines in phase-encoding direction
and had a time average B1 amplitude (continuous-wave equivalent)
of 1.5 mT. Each saturation pulse had a duration of 99 ms and an
interpulsedelayof 100ms.All saturationparameterswere speciﬁcally
optimised to inducemaximal gagCESTeffects at 3.0 T by simulationof
Bloch equations. Thirteen measurements with pre-saturation at
different frequency offsets from the bulk water resonance and one
reference without pre-saturation were recorded during one experi-
ment. Also, corrections of B0 inhomogeneity and motion artifacts
were performed. Residual motion in the 14 CEST image series from
one experiment was compensated by using a non-rigid approach.
Subsequently, Z-spectra, i.e., residual magnetization after selective
pre-saturation (MSat) normalized to the signal of the reference image
(M0) and plotted against the saturation offset frequency (Du), were
corrected for B0 heterogeneities on a pixel-by-pixel basis. For this
purpose, the minimum of Z-spectra as determined by smoothing
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spond to the resonance frequencyofbulkwater protons.Asameasure
for gagCEST effects, the magnetization transfer asymmetry
[MTRasym ¼ MSat(Du)/M0  MSat(Du)/M0] was calculated for
each pixel and frequency offset. Finally, the average MTRasym in the
offset range 0.5e2 ppm, which corresponds to the resonance fre-
quency ofGAGhydroxyl protons,was calculated. The post-processing
was performed using in-house-modiﬁed software (Matlab 7, the
Mathworks, Naticks, MA, USA).
T2mapping was performed using the standard product sequence
of the manufacturer (Siemens Healthcare, Erlangen, Germany). It is a
multi-echo-spin-echo T2-weighted sequence with a TR of 1,940 ms
and 13 different echo times (11.8, 23.6, 35.4, 47.2, 59, 70.8, 82.6, 94.4,
106.2,118,129.8,141.8and153.4ms), avoxel sizeof0.40.43mm3,
and an acquisition time of 5:38 min). T2 relaxation times were
derived from T2 parameter maps by using a pixel-wise, mono-
exponential least-squares-ﬁt analysis (syngo MapIt; Siemens
Healthcare, Erlangen, Germany). The calculation of T2 values in this
sequence included a noise offset correction, which determined sig-
nals that were already hidden in the noise, to discard “noisy” signal
points for ﬁtting of the T2 curve. As long as a sufﬁcient noise
correction is performed, inclusion of multiple echos and long echo
times increases the dynamic range. Due to time restriction the ex-
amination comprised only one half of the knee, including either the
lateral or medial femoral condyle. The decision about the particular
sidewasmadebya seniormusculoskeletal radiologist during theMRI
examination with regard to the individual clinical question.
For obtaining the dGEMRIC images, a 3D T1-weighted VIBE
sequence (TR/TE, 15/2.5, voxel size 0.4  0.4  3 mm3, acquisition
time 3.18 min, ﬁeld-of-view 159  159 mm, imaging matrix
384 384, echo train lengths: 1.) with two excitation ﬂip angles (5
and 26) was performed before and after intravenous administra-
tion of a double dose27 of gadopentetate dimeglumine (0.2mmol/kg
Gd-DTPA,Magnevist, Bayer Vital, Leverkusen, Germany). After Gd-
DTPA administration the subjects had to walk for 15 min, and after
90 min the post-contrast T1-mapping sequences were performed.
The resulting T1 values are referred to as the dGEMRIC values.
Image analysis
Themorphological image analysis was performed on our picture
archiving and communication system (Centricity PACS, version
3.0.4, GE Healthcare Integrated IT Solutions, Barrington, IL) that
allowed for direct comparison and co-registration of anatomic and
functional data sets. The CEST, T1 and T2 parameter maps were
analyzed using an ROI analysis [Fig. 1] according to previous rec-
ommendations11,23,28 on a separate multimodality workstation
(Leonardo, Siemens Healthcare, Erlangen, Germany) by two readers
in consensus.
In healthy cartilage, three ROIs were placed in three consecutive
slices within the normal-appearing cartilage in fat-saturated PD-
weighted images and average values were calculated for further
analysis. Planar ROIs comprised the full thickness of cartilage in one
direction and followed the cartilage curvature about 1 cm along the
other direction. Using the morphological sequences, areas of grade
2 and grade 3 cartilage defects24 and areas after microfracture
therapy were deﬁned. The ROIs covered the damaged area in the
corresponding T1, T2 and CEST maps. ROI placement in three
consecutive slices was not possible due to the small extent of the
damaged areas. The ROIs were placed in the weight-bearing part of
the femoral condyle cartilage and attention was paid not to place
the ROIs near the area where the magic angle artifact would be
expected, i.e., the dorsal femoral condyle. Placement of the ROIs
was visually double-checked to conﬁrm that it was not placed in
areas where obvious artifacts are present. For intraindividualcomparison, three ROIs in three slices were placed into the adjacent
normal-appearing cartilage with a minimum distance of 1 cm to
the defect. Regarding T2 mapping, also the healthy cartilage was
subdivided into a superﬁcial and a deep layer, and equally sized
ROIs were placed separately within these layers as recommended
previously23. Also, for comparison of the T2 mapping results with
those of CEST and dGEMRIC, the mean value of the superﬁcial and
deep ROIs was used.
Statistical analysis
Statistical analysis was performed using the software SAS for
Windows version 9.3 (SAS Institute Inc, North Carolina, USA).
Continuous variables were summarized using descriptive statistics
(e.g., mean, standard deviation, median). Demographic data are
presented as median age and range. The Wilcoxon rank sum test
was performed to check homogeneity in demographic character-
istics within the different populations and included the distribution
of agewithin all three groups. For this purpose statistical tests were
applied but their outcomewill be interpreted solely in a descriptive
manner and no formal statistical conclusions will be drawn from.
Analysis of the examination techniques comprised descriptive
statistics for each group and separately for healthy and damaged
cartilage. Intraindividual differences between healthy and damaged
cartilage were compared using Wilcoxon signed-rank test. We
refrained from using analysis of covariance (ANCOVA) models to
correct for age differences in normal cartilage, because T2 mapping
and dGEMRIC data of the normal cartilage were not normally
distributed and normality could also not induced by log trans-
formation and because the residuals of CEST data were not nor-
mally distributed in the ShapiroeWilk test. Thus, to assess
differences within normal cartilage between the three techniques
the KruskaleWallis test was used. In case of a signiﬁcant result of
the Kruskal-Wallis-test, further post-hoc two-method comparisons
were performed using Wilcoxon rank sum test. Correlation was
assessed using Spearman’s correlation coefﬁcient and 95% conﬁ-
dence intervals were calculated. Coefﬁcient values were rated ac-
cording to Zou et al.29 as no association (0) as well as weak (>0.2,
<0.5), moderate (0.5e0.8), strong (>0.8 < 1.0) and perfect (1.0)
correlations. In all tests, an effect was considered to be signiﬁcant if
the P-value is less than 0.05. This study was not planned as
conﬁrmatory study with the aim of ﬁnal decisionmaking but rather
as exploratory study for a descriptive purpose generating hypoth-
esis which have to be conﬁrmed in further conﬁrmatory studies.
Due to the characteristics of exploratory studies, no adjustment for
multiplicity is required30
Performance of the three techniques regarding the differentia-
tion of cartilage lesions from healthy cartilage was assessed using
receiver-operating characteristic (ROC) analysis and included 64
individuals (only those patients were included inwhom all imaging
methods were performed). Nonparametric estimates and 95%-
conﬁdence intervals for the area under the ROC curves (AUC) were
calculated with AUC ¼ 1 indicating perfect discrimination and
AUC ¼ 0.5 indicating no or random discrimination. Because in pa-
tients of groups 2 and 3 the three biochemical cartilage imaging
techniques were performed both in normal and in damaged carti-
lage, the populations were not independent but had to be consid-
ered as clustered data. Therefore, the statistical comparison of the
AUCs was performed using a non-parametric test for a paired
design with clustered data, described by Lange31.
Results
All results of the ROI analysis of dGEMRIC, T2 mapping and CEST
are presented in Fig. 2 and Table I and their correlations in Table II.
Fig. 1. Placement of the region-of-interests (ROIs) in healthy volunteers (A, B) and patients groups (C, D). In healthy volunteers morphological sequences (proton density weighted,
A) were used to visualize normal cartilage. Color maps of the three functional sequences (here a dGEMRIC map) were overlaid with the morphological image (B) and ROI mea-
surements were performed in three consecutive slices. In patient groups areas of damaged cartilage were also delineated using morphological sequence (arrow in C: repair cartilage
after microfracture therapy). D represents an overlay of a T2 map. ROIs were placed in damaged area (arrow) and in adjacent normal cartilage. Bars on the left of each functional
image demonstrate how the relaxation times of each technique are color coded.
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dGEMRIC, T2 mapping and CEST was possible in all volunteers and
in all patients of repair cartilage group. In chondromalacia group,
analysis was possible for dGEMRIC in 34/40 patients, for T2 map-
ping in 28/40 and for CEST in 34/40 patients. Reasons were con-
traindications against the used contrast agent (n¼ 1), MR sequence
problems (n ¼ 7), and lack of grade 2 or 3 defect within the ex-
amination area when regarding T2 mapping (eight patients).Normal cartilage
CEST showed a statistical signiﬁcant difference (P ¼ 0.02) be-
tween groups 1 (normal-appearing cartilage of healthy volunteers)
and 3 (normal-appearing cartilage of patients who presented with
knee pain and patients after microfracturing), but no statistical
signiﬁcant difference between groups 1 and 2 as well as between
groups 2 and 3 could be detected. dGEMRIC and T2 mapping
revealed no statistically signiﬁcant different T1 and T2 values. There
was some variation of the values of all three techniques (Table I)
both in healthy volunteers (especially dGEMRIC) and in the patient
groups (especially CEST), while T2 mapping produced more con-
stant values with lower standard deviations. In healthy cartilage
mean dGEMRIC values were 915 (group 1: healthy volunteers),802 ms (chondromalacia group) and 747 (repair cartilage group).
Mean T2 values for group 1, 2, and 3 were 52, 52, and 53 ms,
respectively. MeanT2 value of the deep zonewas 47 3.5ms and of
the superﬁcial zone 57  5.3 ms. Mean CEST values were 1.6, 1.4%
and 0.7% for group 1, 2 and 3. In healthy volunteers’ cartilage, a
moderate positive correlation of dGEMRIC and CEST (r ¼ 0.56) was
observed without reaching a signiﬁcance level (P ¼ 0.09, conﬁ-
dence interval [0.13, 0.87]). The other methods assessed showed
no or only weak correlations without signiﬁcance regarding the
healthy cartilage (Table II).Chondromalacia
Areas of grade 2 and 3 chondromalacia had statistically sig-
niﬁcant lower T1 values (mean, 707 vs 802 ms, P < 0.0001),
higher T2 values (mean, 75 ms vs 52 ms, P < 0.0001) and higher
CEST values (mean, 4.8 vs 1.4%, P < 0.001) when compared to
the normal-appearing cartilage of group 2. In this group
dGEMRIC and T2 mapping correlated moderately negative
(r ¼ 0.56, P < 0.01), and T2 mapping and CEST correlated
moderately positive (r ¼ 0.5, P < 0.01; Fig. 3). Of note is
considerable variation of the CEST values even in normal
appearing cartilage (Table I and Fig. 3(d)).
Fig. 2. Delineation of healthy and damaged cartilage using the three functional sequences. The box plots show the differences between the region-of-interest (ROI) values of healthy
and pathologic cartilage in the three patient groups. The small circles outside the whiskers represent outliers. A signiﬁcant decrease in dGEMRIC values and an increase in T2 and
CEST values can be seen both in areas of chondromalacia (group 2) and in areas of repair tissue after microfracturing (group 3).
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Areas of repair cartilage [Fig. 4] presented with statistically
signiﬁcant higher CEST values when compared to normal cartilage
(P < 0.0001). Typically, there were focal areas of increased values
within the microfractured area that lead to the overall increased
values [Fig. 4(d)]. Also, some variation of CEST values was also
present in normal appearing cartilage. The repair tissue also
revealed lower T1 values (mean, 592 vs 747 ms, P < 0.0001). T2
values were overall not statistically signiﬁcant different (63 vs
53 ms, P ¼ 0.54) but higher standard deviation of values in the
repair tissue (SD, 28.7 vs 4.8) was observed. There were examples
with no difference, higher and also lower T2 values compared with
healthy cartilage.Diagnostic performance in differentiating healthy and damaged
cartilage
Fig. 5 presents the ROC curves for analyzing the differentiation
of cartilage lesions from healthy cartilage. Areas under the curve
(AUCs) for dGEMRIC, T2 mapping, and CEST were 0.8, 0.68, and 0.8.
Comparisons of the AUCs yielded non-signiﬁcant differences of T2Table I
Results of the ROI-analysis of healthy and pathologic cartilage is presented as mean and s
between areas of healthy and pathologic cartilage and their corresponding signiﬁcant P-
dGEMRIC(ms)
Healthy
cartilage
Pathologic
cartilage
P-value
Group 1: healthy volunteers N 10
Mean (SD) 915 (353)
Group 2: chondromalacia N 39 34
Mean (SD) 802 (95) 707 (131) 0.0002
Group 3: repair tissue N 18 18
Mean (SD) 747 (100) 592 (99) <0.0001
Note: n.s.: not signiﬁcant, ms: milli seconds, SD: standard deviation, N: number.mapping vs CEST (P ¼ 0.14), CEST vs dGEMRIC (P ¼ 0.89), and T2
mapping vs dGEMRIC (P ¼ 0.12).
Discussion
Biochemical cartilage imaging is a rapidly growing ﬁeld with
several recent advances but there is controversy which functional
technique is superior in detecting or excluding cartilage damage
and in monitoring repair tissue after cartilage therapy9,32. New
techniques like CEST are promising but not established in clinical
routine. We present the ﬁrst prospective study that compared CEST
with dGEMRIC and T2 mapping in healthy cartilage, chon-
dromalacia and repair tissue after MFX of the knee at 3 T.
Healthy cartilage
In healthy cartilage of all 3 groups CEST produced values of <2%
which is in the range of what could be expected from other
cartilage-investigating studies at 3 T33. Thus, CEST proofed to reli-
ably measure cartilage. In statistically signiﬁcant older, but
morphologically normal cartilage of group 3, CEST values were
reduced which can be explained by a reduced GAG-content in oldertandard deviation in the three cohorts for the three functional methods. Differences
values are highlighted
T2 mapping (ms) CEST (%)
Healthy
cartilage
Pathologic
cartilage
P-value Healthy
cartilage
Pathologic
cartilage
P-value
10 10
52.1 (4.2) 1.6 (0.5)
37 28 40 34
51.9 (6.5) 75.4 (29) <0.0001 1.4 (1.3) 4.8 (5.2) 0.0002
19 19 19 19
53.3 (4.8) 62.5 (28.7) n.s. 0.7 (1.3) 7.3 (1.6) <0.0001
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proteoglycans and consecutively also of GAGs34,35 and a GAG loss is
reported to produce lower CEST values10,11,15,16. An additional hint
to the GAG-measurement of the CESTmay be themoderate positive
correlation (r ¼ 0.56) of CEST and dGEMRIC. However, this did not
reach statistical signiﬁcance (P ¼ 0.06, CI e 0.13, 0.87), possibly due
to the small sample size. T2 mapping and dGEMRIC proved to be
concordant, since they revealed no statistically signiﬁcant different
T1 and T2 values in normal appearing cartilage of healthy volun-
teers and also of both patient groups. However, some variation
especially regarding the dGEMRIC values of healthy volunteer’s
cartilage was apparent. The dGEMRIC values of 636 181 ms found
in other studies28 are in line with our values. Full thickness T2
values and T2 values of the superﬁcial and deep cartilage layers
showed a very small distribution. Under the prerequisite that the
measurements are performed in the weight-bearing zone of the
femoral cartilage like in this study, T2 mapping can be considered
as a reliable technique. This may not be true in the posterior region
of the femoral condyle where the magic angle effect and the
different cartilage compositions have to be considered and may
lead to increased T2 values36. Thus special care has to be taken
when analyzing this particular region. Other studies reported
similar T2 values of 56.4  8.9 ms37. Surowiec et al.38 observed
values of 43.2e54.2 ms for the cartilage of the femur depending on
different subregions in 25 similar aged (range 18e35) volunteers.
However, many factors may contribute to the T2 value even in
healthy cartilage, including age, spatial variation, location, and even
different coils39. Other groups reported signiﬁcantly lower
“normal” values of 37.53  6.0240 in similar aged healthy volun-
teers. In our opinion, not the exact T2 value is of most importance to
differentiate normal from pathologic cartilage but the intra-
individual difference.
Damaged cartilage
All three techniques could distinguish normal from damaged
cartilage, and ROC analysis showed non-superiority of either
technique. Chondromalacia grade 2 and 3 had signiﬁcantly higher
CEST values, lower T1 values and higher T2 values when compared
to the normal appearing cartilage in the same patients. We could
also underline our hypothesis, that dGEMRIC and T2 mapping are
negatively correlated in chondromalacia. Also, cartilage areas after
microfracturing presented with signiﬁcantly lower T1 values when
compared to normal-appearing cartilage. Lower T1 values are
known to correspond to a lower GAG content due to various un-
derlying pathologies, mainly OA27,41e44. Trattnig et al.45 reported
statistically signiﬁcant lower T1 values in 10 patients after matrix-
associated cartilage therapy (MACT) and 10 patients after micro-
fracture therapy when compared to the healthy-appearing carti-
lage of the same patients. Kijowski et al.32 reported 228
arthroscopically proven cartilage lesions where 204 (89.5%)
showed increased T2 values. Negative correlations between T1 and
T2 values have also been reported46,47. In repair cartilage, overall
T2 values were slightly but not statistically signiﬁcant different
including cases with increased or decreased and non-altered T2
values. Consequently, T2 mapping did not correlate with dGEMRIC
as we hypothesized. One factor that contributes to the lack of
statistical signiﬁcance might be the reduced sample size of the
repair cartilage group when compared to the chondromalacia
group. However, Welsch et al.48 also reported no differences be-
tween healthy cartilage and full-thickness T2 values of repair tis-
sue after MACT. In other studies, areas after microfracture therapy
showed decreased values49. Apart from the water content and the
collagen network, repair cartilage is supposed to be inﬂuenced by
many other factors, like hemorrhage and calciﬁcation processes26.
Fig. 3. Appearance of chondromalacia. Sagittal proton-density weighted image shows thinning of the cartilage (arrows in A) and normal adjacent cartilage (black arrow). In the
functional sequences (BeD) the area of chondromalacia exhibits decreased dGEMRIC values (B) and increased T2 mapping values (C) when compared to the normal cartilage. Of
note is an increase in T2 in the dorsal femoral condyle, partly explained through a magic angle effect. In this case the CEST values in the damaged area were only slightly and focally
increased (arrows in D). Overall CEST values were not signiﬁcantly altered in this speciﬁc case. Of note is variation of the CEST values in the normal cartilage as well.
C. Rehnitz et al. / Osteoarthritis and Cartilage 22 (2014) 1732e17421738Thus, when evaluating the repair cartilage using T2 mapping, the
longitudinal follow-up might be of most importance rather than
the exact value.
Against our expectations, we observed increased CEST values in
areas of damaged cartilage in patients with chondromalacia and
even more increased values in repair tissue. Also, the signiﬁcant
negative correlation of CEST and dGEMRIC in repair tissue and the
positive correlation of CEST and T2mapping in chondromalaciawas
surprising. We would have expected a positive correlation of CEST
and dGEMRIC as a decrease in the values indicate a GAG loss10,11,16.
One explanation is that evaluation of CEST effects at 3.0 T not only
depends on the GAG content but also on the tissue’s T2 value. CEST
quantiﬁcation depends strongly on the quality of the bulk water
signal, i.e., narrow line width and high intensity, which is likely to
be compromised in cartilage areas with T2 increases. High T2
values might arise both in chondromalacia and especially after
MFX. Here, complex remodeling processes which include bleeding,
calciﬁcation, migration of stem cells together with alterations in the
content of molecules like proteins and glucose can be expected and
contribute to the CEST signal15,26,50e52. At higher ﬁeld strengths the
inﬂuence of T2 on CEST quantiﬁcation is mitigated by higher
chemical-shift dispersion. At 7 T, CEST values in repair cartilage
were found to be decreased and a high correlation (r ¼ 0.701) of
CEST and sodium (23Na) values, which are supposed to directlycorrelate with the GAG content, was observed11. Krusche-Mandl
et al.16 also found decreased CEST values in nine patients 8 years
after autologous osteochondral transplantation (AOT) however
these consist of hyaline or hyaline-like cartilage53, whereas carti-
lage after microfracture therapy consists of a rather ﬁbrous tis-
sue54,55. Singh et al.15 indicated in a small number of only four
volunteers, that the CESTeffect can be expected to be reduced at 3 T
compared to 7 T. They concluded that CESTmight not be valuable at
3 T. This assumption may be partly valid as more sophisticated
measures allowing for high image signal intensities and reliable B0
and motion correction must be used to enable reliable quantiﬁca-
tion of CEST effects at 3.0 T. However, with these measures in place,
CEST is very well expected to be a valuable clinical tool at 3.0 T.
Nevertheless, it must be noted that evaluation of cartilage areas
with strongly increased T2 values or severely altered composition
may be an ultimate obstacle for CEST at 3.0 T. As a future
perspective, one potential solution to minimize this issue might be
to correct CEST values for T2 effects, which may be possible using
modiﬁcations of existing CEST correction algorithms when T1 or T2
values are known56,57. Other studies showed that the CEST tech-
nique is feasible in measuring GAG at 3 T. Kim et al.12 demonstrated
the possibility of GAG measurements of intervertebral discs at 3 T
after that the proof of concept was made by Saar et al. at ultra-
highﬁeld strengths13. Haneder et al. showed that evaluation of GAG
Fig. 4. Appearance of repair tissue. The area of repair tissue after microfracturing is depicted in sagittal proton-density weighted image (arrows in A). In the functional sequences
(BeD) the area of repair tissue exhibits decreased dGEMRIC values (arrows in B) when compared to the normal cartilage. T2 mapping values (C) where superﬁcially slightly (arrows)
but overall not increased. Of note is again an increase in T2 in the dorsal femoral condyle, partly explained through a magic angle effect. CEST (D) depicts an area of focally increased
values (arrows). Some variation of the CEST in normal cartilage is also present.
C. Rehnitz et al. / Osteoarthritis and Cartilage 22 (2014) 1732e1742 1739content in degenerated intervertebral discs in patients with low
back pain is feasible at 3 T58.
Thus, both T2 mapping and dGEMRIC could be recommended
to detect and characterize damaged cartilage in chondromalacia
patients. dGEMRIC is by far more time-consuming and needs
contrast agent. T2 mapping is easy to perform and to evaluate and
produces concordant values. Therefore, T2 mapping can be rec-
ommended as ﬁrst-line method that could be integrated into a
routine protocol to early detect or to follow-up patients with
chondromalacia. However, not the T2 value itself is of most
importance but the intraindividual difference. dGEMRIC is also
valuable in analysis of repair tissue after microfracture therapy.
Here, the areas of GAG-depleted repair tissue can be easily
detected and quantitatively evaluated. CEST has a high potential to
measure GAG non-invasively and appears to reliably detect normal
cartilage and to be as good as the other methods to show cartilage
damage. CEST might measure GAG at least in entirely healthy
cartilage at 3 T and might also indicate early GAG depletion in
older but morphologically normal cartilage but analysis especially
of repair cartilage is challenging.
Limitations
The three subpopulations were not balanced. The age of the
healthy volunteers was signiﬁcantly lower, and this has probablyinﬂuenced the comparison of the normal-appearing cartilage. A
future goal would therefore be to evaluate whether similar-aged
but non-symptomatic cartilage of volunteers is equal to morpho-
logically normal-appearing cartilage in these patient groups. Not all
of the patients received all imaging techniques. This is mainly
attributed to the clinical setting of this study. Due to time restric-
tion and also patients’ compliance, it was not always possible to
repeat sequences in cases of inadequate imaging, for instance due
to technical problems, especially if the examination time was too
long. Moreover, we had no arthroscopic or histologic conﬁrmation.
This would be desirable to characterize the areas that showed
increased CEST values and to assess early degeneration in
morphological normal-appearing cartilage. The CEST sequence is
currently at an early stage of its development and some variation of
values even in normal appearing cartilage is present that currently
may limit the detection of subtle cartilage changes. However, this
variation is also present at higher ﬁeld strengths11,16 and the pre-
sented 3 T CEST image quality is high when compared with recent
publications at 3 T33,59
Conclusion
All three 3 T techniques can readily be used to evaluate cartilage
properties with particular advantages for each technique. CEST is
feasible in a clinical setting at 3 T and detects normal and damaged
Fig. 5. ROC analyses to assess diagnostic performance of the three functional tech-
niques in differentiating healthy from diseased cartilage. Areas under the curve are
displayed at the bottom. Differences between the areas under the curves were not
signiﬁcant.
C. Rehnitz et al. / Osteoarthritis and Cartilage 22 (2014) 1732e17421740cartilage with non-inferiority when compared with dGEMRIC and
T2 mapping. CEST might indicate early GAG-loss in older cartilage.
At this early stage of development, some variation of the CEST
signal is present in normal appearing cartilage and confounded by
complex remodeling processes including T2 effects in severely
damaged cartilage, especially after MFX. Thus, T2 correction algo-
rithms may be helpful at 3 T. T2 mapping may be recommended to
assess chondromalacia, while dGEMRIC is rather advantageous in
the analysis of repair cartilage after microfracture therapy.Author contribution
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